Recent Advances in Drug Development for Hair Loss
International Journal of Molecular Sciences · 08.04.2025 · 26 (8) · 3461
DOI: 10.3390/ijms26083461 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.04.2025. Verfasst von Jino Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: New Hair Institute, Seoul 06034, Republic of Korea. Hauptthemen laut MEDLINE: Alopecia, Drug Development. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean Fund for Regenerative Medicine funded by Ministry of Science and ICT, and Ministry of Health and Welfare, Republic of Korea, Korean Fund for Regenerative Medicine, Ministry of Science and ICT.
Abstract (Originalsprache)
Hair loss disorders pose a substantial global health burden, affecting millions of individuals and significantly impacting quality of life. Despite the widespread use of approved therapeutics like minoxidil and finasteride, their clinical efficacy remains limited. These challenges underscore the pressing need for more targeted and effective therapeutic solutions. This review examines the latest innovations in hair loss drug discovery, with a focus on small-molecule inhibitors, biologics, and stem cell-based therapies. By integrating insights from molecular mechanisms and leveraging advancements in research methods, the development of next-generation therapeutics holds the potential to transform the clinical management of hair loss disorders. Future drug development for hair loss disorders should prioritize antibody therapy and cell-based treatments, as these approaches offer unprecedented opportunities to address the limitations of existing options. Antibody therapies enable precise targeting of key molecular pathways involved in hair follicle regulation, providing highly specific and effective interventions. Similarly, cell-based therapies, including stem cell transplantation and dermal papilla cell regeneration, directly address the regenerative capacity of hair follicles, offering transformative potential for hair restoration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- New Hair Institute, Seoul 06034, Republic of Korea.
- Institute for Human Tissue Restoration, Department of Plastic and Reconstructive Surgery, Yonsei University College of Medicine, Seoul 06134, Republic of Korea.
- Epi Biotech Co., Ltd., Incheon 21983, Republic of Korea.
ORCID-Profile: Seung-Yong Song
Förderung
- Korean Fund for Regenerative Medicine funded by Ministry of Science and ICT, and Ministry of Health and Welfare, Republic of Korea
- Korean Fund for Regenerative Medicine
- Ministry of Science and ICT
- Ministry of Health and Welfare, Republic of Korea
Zitieren
APA
Kim, J., Song, S. Y., & Sung, J. H. (2025). Recent Advances in Drug Development for Hair Loss. International Journal of Molecular Sciences, 26(8), 3461. https://doi.org/10.3390/ijms26083461
Vancouver
Kim J, Song SY, Sung JH. Recent Advances in Drug Development for Hair Loss. International Journal of Molecular Sciences. 2025;26(8):3461. doi:10.3390/ijms26083461
BibTeX
@article{Kim2025,
author = {Kim, Jino and Song, Seung-Yong and Sung, Jong-Hyuk},
title = {Recent Advances in Drug Development for Hair Loss},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {8},
pages = {3461},
doi = {10.3390/ijms26083461}
}
EUVIMED